BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33519800)

  • 1. Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications.
    Zhang B; Zhao M; Lu Q
    Front Immunol; 2020; 11():575712. PubMed ID: 33519800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus.
    Perez-Hernandez J; Cortes R
    Dis Markers; 2015; 2015():613536. PubMed ID: 26435565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effects of extracellular vesicles from mesenchymal stromal cells: Implication for therapeutic approach in autoimmune diseases.
    Liao HJ; Hsu PN
    Kaohsiung J Med Sci; 2024 Jun; 40(6):520-529. PubMed ID: 38712483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.
    Yang C; Sun J; Tian Y; Li H; Zhang L; Yang J; Wang J; Zhang J; Yan S; Xu D
    Front Immunol; 2021; 12():714832. PubMed ID: 34603289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flood Control: How Milk-Derived Extracellular Vesicles Can Help to Improve the Intestinal Barrier Function and Break the Gut-Joint Axis in Rheumatoid Arthritis.
    Aarts J; Boleij A; Pieters BCH; Feitsma AL; van Neerven RJJ; Ten Klooster JP; M'Rabet L; Arntz OJ; Koenders MI; van de Loo FAJ
    Front Immunol; 2021; 12():703277. PubMed ID: 34394100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus.
    Perez-Hernandez J; Redon J; Cortes R
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles: A new therapeutic strategy for joint conditions.
    Tofiño-Vian M; Guillén MI; Alcaraz MJ
    Biochem Pharmacol; 2018 Jul; 153():134-146. PubMed ID: 29427625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis.
    Liu H; Li R; Liu T; Yang L; Yin G; Xie Q
    Front Immunol; 2020; 11():1912. PubMed ID: 32973792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of extracellular vesicles in autoimmune diseases.
    Turpin D; Truchetet ME; Faustin B; Augusto JF; Contin-Bordes C; Brisson A; Blanco P; Duffau P
    Autoimmun Rev; 2016 Feb; 15(2):174-83. PubMed ID: 26554931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of magnetosorbents in the immunodiagnosis and therapy of systemic lupus erythematosus and rheumatoid arthritis].
    Zborovskiĭ AB; Gontar' IP
    Klin Med (Mosk); 2001; 79(2):42-5. PubMed ID: 11419085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles Tune the Immune System in Renal Disease: A Focus on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Thrombotic Microangiopathy and ANCA-Vasculitis.
    Mazzariol M; Camussi G; Brizzi MF
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications.
    Zhao Y; Wei W; Liu ML
    J Autoimmun; 2020 Dec; 115():102540. PubMed ID: 32893081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Extracellular Vesicles in Autoimmune Pathogenesis.
    Wu WC; Song SJ; Zhang Y; Li X
    Front Immunol; 2020; 11():579043. PubMed ID: 33072123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis.
    Alaaeddine N; Hassan GS; Yacoub D; Mourad W
    Clin Dev Immunol; 2012; 2012():490148. PubMed ID: 22110533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis.
    Ulivieri C; Baldari CT
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune diseases in China.
    Li R; Sun X; Liu X; Yang Y; Li Z
    Adv Immunol; 2019; 144():173-216. PubMed ID: 31699217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Atehortúa L; Rojas M; Vásquez G; Muñoz-Vahos CH; Vanegas-García A; Posada-Duque RA; Castaño D
    Arthritis Res Ther; 2019 Jan; 21(1):34. PubMed ID: 30674349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune Connective Tissue Diseases: Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Rose J
    Emerg Med Clin North Am; 2022 Feb; 40(1):179-191. PubMed ID: 34782087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rheumatoid arthritis (RA) and systemic lupus erythematosus(SLE)].
    Trendelenburg M; Schifferli J
    Ther Umsch; 2005 May; 62(5):263. PubMed ID: 15945213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.